Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Albert Einstein College of Medicine, U.S.
Researchers from Albert Einstein College of Medicine, U.S. provide details of new studies and findings
November 7th, 2006
Researchers from Albert Einstein College of Medicine, U.S. provide details of new studies and findings. This trend article about Albert Einstein College of Medicine, U.S. is an immediate alert from LawRx to identify developing directions of research. Study 1: eNOS gene therapy exacerbates hepatic ischemia-reperfusion injury in diabetes . "Previous studies indicate that endothelial nitric oxide synthase (eNOS) function is impaired in diabetes as a result of increased vascular generation of reactive oxygen species. We hypothesized that eNOS gene therapy would augment NO center dot bioavailability and protect against hepatic...
Source: Drug Law Weekly (2006-11-07)
|
